Fund HoldingsBain Capital Life Sciences Investors, LLC

Total Portfolio Value
$961.18M
Total Bought
$27.24M
Total Sold
$14.62M
Net Transaction
+$12.62M
Filing Period:
Securities
SharesValue ($K)
Q2 2024
Q3 2024
Change
Q2 2024
Q3 2024
Weight (%)
Change
NUVALENT INC2,697,2672,697,2670204,615275,93028.71%+71,316
ANNEXON INC(ANNX)8,449,2088,449,748+54041,40150,0235.20%+8,621
CIDARA THERAPEUTICS INC0703,080+703,08007,5580.79%+7,558
DISC MEDICINE INC(IRON)1,795,7351,795,735080,93488,2429.18%+7,309
SOLID BIOSCIENCES INC4,034,5824,034,582022,87628,1212.93%+5,245
DIANTHUS THERAPEUTICS INC(DNTH)3,013,4233,013,423077,98782,5088.58%+4,520
SAVARA INC(SVRA)14,565,45714,565,457058,69961,7586.43%+3,059
MARINUS PHARMACEUTICALS INC2,267,6802,693,380+425,7002,6534,7400.49%+2,087
RAPID MICRO BIOSYSTEMS INC8,434,5608,434,56005,5677,5070.78%+1,940
X4 PHARMACEUTICALS INC16,915,78416,915,78409,81111,3221.18%+1,511
C4 THERAPEUTICS INC1,111,9101,111,91005,1376,3380.66%+1,201
NAUTILUS BIOTECHNOLOGY INC2,000,0002,000,00004,6805,7000.59%+1,020
CABALETTA BIO INC1,649,9642,760,888+1,110,92412,34213,0311.36%+690
ATEA PHARMACEUTICALS INC2,485,6382,485,63808,2278,3270.87%+99
XILIO THERAPEUTICS INC3,785,4504,566,817+781,3673,5873,5970.37%+11
INVIVYD INC1,799,5951,799,59501,9801,8360.19%-144
NEWAMSTERDAM PHARMA COMPANY
*W EXP 99/99/999
100,000100,00008727000.07%-172
PHARVARIS N V
COM
3,303,3813,303,381062,10461,1796.36%-925
MERSANA THERAPEUTICS INC8,663,6738,663,673017,41416,3741.70%-1,040
ACLARIS THERAPEUTICS INC(ACRS)1,000,0000-1,000,0001,1000-1,100
TANGO THERAPEUTICS INC(TNGX)2,892,6632,712,008-180,65524,81920,8822.17%-3,937
CENTURY THERAPEUTICS INC5,410,3615,410,361013,7969,2520.96%-4,545
SYROS PHARMACEUTICALS INC2,749,8082,750,151+34314,1895,9130.62%-8,276
KYVERNA THERAPEUTICS INC3,368,3703,368,370025,26316,4711.71%-8,791
ARCUTIS BIOTHERAPEUTICS INC(ARQT)1,030,7030-1,030,7039,5860-9,586
NEWAMSTERDAM PHARMA COMPANY
ORDINARY SHARES
10,473,91310,473,9130201,204173,86718.09%-27,337
Page 1 of 1